BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29991092)

  • 1. Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives.
    Pedicino D; Giglio AF; Ruggio A; Massaro G; D'Aiello A; Trotta F; Lucci C; Graziani F; Biasucci LM; Crea F; Liuzzo G
    Thromb Haemost; 2018 Aug; 118(8):1352-1369. PubMed ID: 29991092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
    Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis and immunity: A perspective.
    Abdolmaleki F; Gheibi Hayat SM; Bianconi V; Johnston TP; Sahebkar A
    Trends Cardiovasc Med; 2019 Aug; 29(6):363-371. PubMed ID: 30292470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism-inflammasome crosstalk shapes innate and adaptive immunity.
    Wu J; Sun X; Jiang P
    Cell Chem Biol; 2024 May; 31(5):884-903. PubMed ID: 38759617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk.
    Hachim MY; Khalil BA; Elemam NM; Maghazachi AA
    J Leukoc Biol; 2020 Jul; 108(1):323-338. PubMed ID: 32083338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy.
    Karan D
    Front Immunol; 2018; 9():3028. PubMed ID: 30631327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate and adaptive effects of inflammasomes on T cell responses.
    Dostert C; Ludigs K; Guarda G
    Curr Opin Immunol; 2013 Jun; 25(3):359-65. PubMed ID: 23478069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementing the inflammasome.
    Triantafilou M; Hughes TR; Morgan BP; Triantafilou K
    Immunology; 2016 Feb; 147(2):152-64. PubMed ID: 26572245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2016 Jeffrey M. Hoeg Award Lecture.
    Rouwet E; Lutgens E
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1678-1688. PubMed ID: 29930003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in atherosclerosis: transition from theory to practice.
    Libby P; Okamoto Y; Rocha VZ; Folco E
    Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination Strategies and Immune Modulation of Atherosclerosis.
    Nilsson J; Hansson GK
    Circ Res; 2020 Apr; 126(9):1281-1296. PubMed ID: 32324498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasomes cross-talk with lymphocytes to connect the innate and adaptive immune response.
    Zhang H; Gao J; Tang Y; Jin T; Tao J
    J Adv Res; 2023 Dec; 54():181-193. PubMed ID: 36681114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of innate and adaptive immune responses on atherosclerosis.
    Witztum JL; Lichtman AH
    Annu Rev Pathol; 2014; 9():73-102. PubMed ID: 23937439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-Inflammation in Atherosclerosis: A New Twist in an Old Tale.
    Talepoor AG; Fouladseresht H; Khosropanah S; Doroudchi M
    Endocr Metab Immune Disord Drug Targets; 2020; 20(4):525-545. PubMed ID: 31622224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis regulation by the inflammasome signaling pathway.
    Negash AA; Gale M
    Immunol Rev; 2015 May; 265(1):143-55. PubMed ID: 25879290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 19. "TRP inflammation" relationship in cardiovascular system.
    Numata T; Takahashi K; Inoue R
    Semin Immunopathol; 2016 May; 38(3):339-56. PubMed ID: 26482920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
    Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.